FDOPA PET Imaging Pipeline for Early Antipsychotic Response Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for predicting treatment response in patients with psychotic disorders are inefficient, taking an average of 4 years and requiring costly empirical trials due to the lack of accurate imaging-based markers, and existing PET imaging techniques are too lengthy and impractical for routine clinical use.
Innovation Solution
A fully-automated analysis pipeline for PET imaging using dopaminergic radiotracers, such as [18F]FDOPA, with a simplified acquisition protocol that allows for a single PET image analysis within 20 minutes, followed by an automated image analysis and prediction algorithm to determine treatment response.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If [18F]FDOPA PET imaging is used to measure dopaminergic function, then treatment response prediction accuracy is improved, but scan duration becomes too long (95 minutes) for routine clinical practice
Solution Approach 1:
The patent applies preliminary action by acquiring PET images at multiple time points during the uptake phase (e.g., 5, 10, 15, 20 minutes) before the traditional 95-minute scan completes. This allows the system to capture dopaminergic function dynamics early, enabling prediction without requiring the full prolonged scan duration.
Solution Approach 2:
The patent uses partial action by performing analysis on a subset of the full scan data - specifically using only the uptake phase images (first 20 minutes) rather than the complete 95-minute scan. This partial data suffices for accurate prediction while dramatically reducing scan time requirements for routine clinical use.
2Measurement precision
If traditional [18F]FDOPA PET imaging protocol is used, then dopaminergic function measurement accuracy is maintained, but clinical feasibility and cost-effectiveness deteriorate due to long scan time and high cost
Solution Approach 1:
The system performs preliminary image acquisition during the uptake phase and preliminary analysis to generate prediction outputs before the traditional full scan would complete. This allows accurate dopaminergic function measurement to be achieved in advance, improving clinical feasibility by reducing the time and cost burden on patients and healthcare systems.
Solution Approach 2:
The patent creates a simplified copy of the full PET scan protocol that achieves comparable measurement accuracy with reduced time and cost. By using the same radiotracer and analysis methodology but applied to a shortened acquisition window, the system produces equivalent predictive information at lower cost and with improved clinical feasibility.
3Measurement precision
If empirical treatment trials are conducted to identify non-responders, then treatment selection accuracy is improved, but time delay increases to average 4 years and patient burden increases
Solution Approach 1:
The patent applies preliminary action by conducting dopaminergic function measurement and treatment response prediction at the time of illness presentation, before empirical treatment trials begin. This advance prediction identifies non-responders early, allowing clinicians to select appropriate treatments from the outset and eliminating the 4-year delay associated with trial-and-error approaches.
Solution Approach 2:
The system provides immediate feedback about treatment response likelihood based on dopaminergic function measurements. This feedback mechanism allows clinicians to adjust treatment selection in real-time based on objective biomarkers rather than waiting years for empirical trial results, significantly reducing time loss and patient burden.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid prediction of treatment response within days of illness onset, reducing patient burden and costs by guiding treatment choice prospectively and avoiding lengthy trial-and-error approaches.
Implementation Method 1
a PET image obtained using a DOPA labelled radiotracer
Data Source
AI summary
A neuroimaging-based approach to predict treatment response in mental disorders by acquiring and analysing brain PET dopamine measures from patients. The method uses a short, simplified protocol for [18F]FDOPA brain PET imaging adapted for clinical practice. Individual [18F]FDOPA brain PET data are then quantified with a fully-automated analysis pipeline to extract information on the dopamine function of the subject. This information coupled with clinical information is run through a prediction algorithm to identify those patients whose illness will not respond to conventional antipsychotics.